Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

Felipe A. Medeiros, Thomas R. Walters, Miriam Kolko, Michael Coote, Marina Bejanian, Margot L. Goodkin, Qiang Guo, Jane Zhang, Michael R. Robinson, Robert N. Weinreb, Ashish Agar, Renuka Bathijia, Lance Liu, Tim Roberts, Christoph Faschinger, Clemens Vass, Nathalie Collignon, Ana Cláudia Alves Pereira, Rubens Belfort de Mattos, Fernando Justino Dantas, M. J. Silva, Fábio Nishimura Kanadani, Leopoldo Magacho dos Santos Silva, Tiago Prata, Daniella Bach‐Holm, Jimmy Lai, Clement C. Tham, György Bátor, Lajos Szalczer, Balázs Varsányi, Eytan Z. Blumenthal, Orna Geyer, Shmuel Lavartovsky, Tamar Pedut-Kloizman, Nir Shoham-Hazon, Silvio Lujan, Benjamin Abela, Robert Edward T. Ang, Edgar U. Leuenberger, Harvey S. Uy, Maria Imelda R. Yap-Veloso, Piotr Fryczkowski, Piotr Jurowski, Bartłomiej J. Kałużny, Józef Kalużny, Marta Misiuk‐Hojło, Krystyna Raczyńska, Wioletta Tomczyk-Dorozynska, J Wasyluk, S Zalewski, Tomasz Żarnowski, J. García–Sánchez, R. Giménez-Gómez, Elena Millà Griñó, Alfonso Antón López, Merce Guarro Miralles, Javier Montero Moreno, Vicente Polo, Enrique Cervera Taulet, Beatriz Ponte, Yingying Chen, Yuan‐Chieh Lee, Louis Alpern, Michael S. Berlin, Jacob W. Brubaker, Delmar R. Caldwell, Andrew Camp, Louis B. Cantor, Ronald Caronia, Charles J. Crane, Douglas G. Day, Eran Duzman, John L Elfervig, Shérif M. El-Harazi, Richard Evans, Ann C. Fisher, William J. Flynn, C. Stephen Foster, R. E. P. Frenkel, Raj Goyal, Ronald L. Gross, Paul J. Hartman, William L. Haynes, Gary Jerkins, Janet Kim, Max Kim, Bradley Kwapiszeski, Benjamin Lambright, Christine L. Larsen, James D. Lehmann, Jeffrey Levenson, Dwayne K. Logan, Brian McMillan, Joseph R. Martel, Hylton R. Mayer, Sayoko E. Moroi, Andrew L. MoyesOphthalmology 2020 · DOI

Abstract

Both dose strengths of bimatoprost implant met the primary end point of noninferiority to timolol through week 12. One year after 3 administrations, IOP was controlled in most subjects without additional treatment. The risk-benefit assessment favored the 10-μg implant over the 15-μg implant. Ongoing studies are evaluating other administration regimens to reduce the potential for CECD loss. The bimatoprost implant has potential to improve adherence and reduce treatment burden in glaucoma.
BibTeX
@inproceedings{medeiros2020phase,
  author = {Felipe A. Medeiros and Thomas R. Walters and Miriam Kolko and Michael Coote and Marina Bejanian and Margot L. Goodkin and Qiang Guo and Jane Zhang and Michael R. Robinson and Robert N. Weinreb and Ashish Agar and Michael Coote and Renuka Bathijia and Lance Liu and Tim Roberts and Christoph Faschinger and Clemens Vass and Nathalie Collignon and Ana Cláudia Alves Pereira and Rubens Belfort de Mattos and Fernando Justino Dantas and M. J. Silva and Fábio Nishimura Kanadani and Leopoldo Magacho dos Santos Silva and Tiago Prata and Daniella Bach‐Holm and Miriam Kolko and Jimmy Lai and Clement C. Tham and György Bátor and Lajos Szalczer and Balázs Varsányi and Eytan Z. Blumenthal and Orna Geyer and Shmuel Lavartovsky and Tamar Pedut-Kloizman and Nir Shoham-Hazon and Silvio Lujan and Benjamin Abela and Robert Edward T. Ang and Edgar U. Leuenberger and Harvey S. Uy and Maria Imelda R. Yap-Veloso and Piotr Fryczkowski and Piotr Jurowski and Bartłomiej J. Kałużny and Józef Kalużny and Marta Misiuk‐Hojło and Krystyna Raczyńska and Wioletta Tomczyk-Dorozynska and J Wasyluk and S Zalewski and Tomasz Żarnowski and J. García–Sánchez and R. Giménez-Gómez and Elena Millà Griñó and Alfonso Antón López and Merce Guarro Miralles and Javier Montero Moreno and Vicente Polo and Enrique Cervera Taulet and Beatriz Ponte and Yingying Chen and Yuan‐Chieh Lee and Louis Alpern and Michael S. Berlin and Jacob W. Brubaker and Delmar R. Caldwell and Andrew Camp and Louis B. Cantor and Ronald Caronia and Charles J. Crane and Douglas G. Day and Eran Duzman and John L Elfervig and Shérif M. El-Harazi and Richard Evans and Ann C. Fisher and William J. Flynn and C. Stephen Foster and R. E. P. Frenkel and Raj Goyal and Ronald L. Gross and Paul J. Hartman and William L. Haynes and Gary Jerkins and Janet Kim and Max Kim and Bradley Kwapiszeski and Benjamin Lambright and Christine L. Larsen and James D. Lehmann and Jeffrey Levenson and Dwayne K. Logan and Brian McMillan and Joseph R. Martel and Hylton R. Mayer and Felipe A. Medeiros and Sayoko E. Moroi and Andrew L. Moyes},
  title = {{Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)}},
  booktitle = {Ophthalmology},
  year = {2020},
  doi = {10.1016/j.ophtha.2020.06.018},
}

Loading related content...

Figure